salim khakoo
Title
Cited by
Cited by
Year
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ...
Nature 461 (7265), 798-801, 2009
24982009
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo, CL Thio, MP Martin, CR Brooks, X Gao, J Astemborski, ...
Science 305 (5685), 872-874, 2004
13242004
HIV-1 adaptation to NK-cell-mediated immune pressure
G Alter, D Heckerman, A Schneidewind, L Fadda, CM Kadie, JM Carlson, ...
Nature 476 (7358), 96-100, 2011
3662011
KIR and disease: a model system or system of models?
SI Khakoo, M Carrington
Immunological reviews 214 (1), 186-201, 2006
3122006
Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
SI Khakoo, R Rajalingam, BP Shum, K Weidenbach, L Flodin, DG Muir, ...
Immunity 12 (6), 687-698, 2000
3122000
MAIT cells are activated during human viral infections
B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ...
Nature communications 7 (1), 1-11, 2016
2912016
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ...
Annals of internal medicine 158 (4), 235-245, 2013
2032013
Activation of natural killer cells during acute infection with hepatitis C virus
B Amadei, S Urbani, A Cazaly, P Fisicaro, A Zerbini, P Ahmed, G Missale, ...
Gastroenterology 138 (4), 1536-1545, 2010
2012010
Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus
S Knapp, U Warshow, D Hegazy, L Brackenbury, IN Guha, A Fowell, ...
Hepatology 51 (4), 1168-1175, 2010
1962010
Peptide antagonism as a mechanism for NK cell activation
L Fadda, G Borhis, P Ahmed, K Cheent, SV Pageon, A Cazaly, ...
Proceedings of the National Academy of Sciences 107 (22), 10160-10165, 2010
1632010
Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions
S Khakoo, P Glue, L Grellier, B Wells, A Bell, C Dash, I Murray‐Lyon, ...
British journal of clinical pharmacology 46 (6), 563-570, 1998
1601998
Natural killer cells: integrating diversity with function
K Cheent, SI Khakoo
Immunology 126 (4), 449-457, 2009
1492009
Hanging in the balance
AP Williams, AR Bateman, SI Khakoo
Molecular interventions 5 (4), 226, 2005
1312005
KIR/HLA interactions and pathogen immunity
KM Jamil, SI Khakoo
Journal of Biomedicine and Biotechnology 2011, 2011
1282011
Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses
S Pelletier, C Drouin, N Bédard, SI Khakoo, J Bruneau, NH Shoukry
Journal of hepatology 53 (5), 805-816, 2010
1262010
Histological assessment of the Sydney classification of endoscopic gastritis.
SI Khakoo, AJ Lobo, NA Shepherd, SP Wilkinson
Gut 35 (9), 1172-1175, 1994
1211994
Natural killer cells and hepatitis C: action and reaction
K Cheent, SI Khakoo
Gut 60 (2), 268-278, 2011
1182011
Conservation and variation in human and common chimpanzee CD94 and NKG2 genes
BP Shum, LR Flodin, DG Muir, R Rajalingam, SI Khakoo, S Cleland, ...
The Journal of Immunology 168 (1), 240-252, 2002
1182002
Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience
SM Vidal, SI Khakoo, CA Biron
Current opinion in virology 1 (6), 497-512, 2011
1112011
Understanding the host genetics of chronic hepatitis B and C
M Thursz, L Yee, S Khakoo
Seminars in liver disease 31 (02), 115-127, 2011
1052011
The system can't perform the operation now. Try again later.
Articles 1–20